RENVI

Details for Australian Trade Mark No. 1387733 (hide)

Owner Amylin Pharmaceuticals, Inc. incorporated in the State

Convention US 30 September 2010 85/142307

Service Spruson & Ferguson

Various Convention priority claimed: 30 September 2010, United States of America, No. 85/142307 in respect of PHARMACEUTICAL PREPARATIONS, NAMELY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF L1POATROPHY, LIPODYSTROPHY, HYPOTHALMIC AMENORRHEA, L

Filing Date 7 October 2010

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, hypothalamic amenorrhea, leptin deficiency, metabolic disorders, endocrine conditions and disorders, diabetes, hepatomegaly, hormonal diseases and disorders, obesity, eating disorders, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases, neurological disorders, psychiatric disorders, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders

Event Publications

28 October 2010 Application filed

3 February 2011 Application Accepted

26 May 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1387734-CENTARCA

1387732-Rossi ; Ross ; Rossy